INTRODUCTION
Expression of genes for aromatic amino acid biosynthesis and uptake in
Escherichia coli is regulated by the transcription factor TyrR, which represses or activates nine separate transcriptional units encompassing 12 genes (
1,
2). TyrR controls the expression of genes encoding enzymes of the shikimate pathway for synthesis of chorismate (
aroF,
aroG, and
aroL); for production of the aromatic amino acids phenylalanine and tyrosine (
tyrA and
tyrB) and folic acid (
folA), which are derived from chorismate; genes encoding several aromatic amino acid transporters (
aroP,
mtr, and
tyrP); and TyrR itself (
tyrR) (
1,
2). To regulate expression of these genes, TyrR binds to DNA at sites related to the consensus sequence TGTAAA-N
6-TTTACA that overlap or are adjacent to sigma-70 promoters (
3–5). The degree of agreement with the consensus sequence affects the affinity of TyrR binding to the sequence (
3,
5). Generally, strong TyrR boxes have at least 10 nucleotide matches to the consensus, a high degree of sequence symmetry, and an AT-rich spacer sequence, while weak boxes have fewer than 10 matching nucleotides and less symmetry (
6,
7). A key feature of functional TyrR boxes is the invariable G-N
14-C bases; changes to either nucleotide result in a loss of TyrR binding. Each of the three aromatic amino acids, namely, tryptophan, phenylalanine, and tyrosine, functions as cofactors for TyrR, modulating its regulatory action such that each regulon member is uniquely controlled. The aromatic amino acids bind TyrR at two sites, one ATP-independent binding site for tryptophan and phenylalanine and a second ATP-dependent tyrosine binding site (
1,
5). TyrR exists as a dimer in the absence of cofactors (
8), but in the presence of tyrosine and ATP it undergoes further polymerization to form a hexamer, which may then interact simultaneously with multiple TyrR boxes (
9,
10). Phenylalanine can facilitate the cooperative binding of TyrR dimers across multiple boxes through dimer-dimer interactions (
11,
12).
TyrR functions as both a transcriptional repressor and activator, in some cases exhibiting both capacities at the same promoter. Promoters repressed by TyrR in the presence of tyrosine contain at least two adjacent TyrR boxes, one strong and one weak (
7). The weak box is typically closer to, or overlapping with, the core promoter (−35 or −10 elements), and cofactor-mediated binding at this low-affinity site requires an adjacent strong box. Repression may involve the exclusion of RNA polymerase from the promoter, as is the case for
tyrP, or the inhibition of subsequent steps of transcription, such as open complex formation or promoter escape, as for
tyrB (
13–16). TyrR activation of transcription occurs through direct interactions with the RNA polymerase alpha subunit carboxy-terminal domain, which recruits RNA polymerase to the promoter or otherwise stabilizes its interaction with the DNA (
1). This requires TyrR to be positioned upstream of the −35 promoter element and on the same face of DNA to allow direct contact between the N-terminal domain of TyrR and RNA polymerase (
17,
18). A further requirement for TyrR-mediated gene activation is an imperfect promoter, as seen with the GC-rich −10 elements of the
tyrP,
mtr, and
aroPP3 genes (
1,
19). In all instances of TyrR regulation, the location of the TyrR boxes and the spacing between them and the promoter are crucial determinants for the mode of transcriptional control exhibited by TyrR, which is further modulated by the oligomerization status of the protein influenced by the presence of aromatic amino acids (
12,
14).
The TyrR regulon has been extensively studied in
E. coli; however, in other gammaproteobacteria, additional TyrR-regulated genes have been identified that encode functions accessory to or beyond aromatic amino acid biosynthesis and uptake. The
tpl gene of
Citrobacter freundii and
Erwinia herbicola, encoding tyrosine phenol lyase for tyrosine catabolism, is upregulated by cooperative TyrR binding across three boxes in conjunction with DNA-bending protein integration host factor (IHF) and cAMP receptor protein (
20–22). In the entomopathogenic bacterium
Photorhabdus luminescens, expression of the phenylalanine-ammonium lyase gene
sltA is controlled by TyrR and is required for production of a stilbene antibiotic (
23). The acid-inducible genes
aniC and
hyaB of
Salmonella enterica subsp.
enterica serovar Typhimurium, encoding an arginine:agmatine symporter and hydrogenlyase subunit, respectively, are activated by TyrR with tyrosine under acidic growth conditions (
24). The
Pseudomonas TyrR homologue, PhhR, controls genes for metabolism of aromatic compounds and amino acid catabolism, in addition to those for aromatic amino acid biosynthesis (
25–27). Rodionov et al. inferred from reconstruction of transcriptional networks that TyrR has undergone regulon expansion in the
Shewanella genus, controlling degradation pathways for phenylalanine, tyrosine, branched-chain amino acids, proline, and oligopeptides, in addition to the glyoxylate cycle for carbohydrate synthesis (
28). Furthermore, genomic SELEX and bioinformatic analysis suggest that there are more TyrR regulon members in
E. coli; however, direct regulation of the predicted TyrR-controlled genes is yet to be demonstrated (
1,
2). The differences in TyrR-regulated genes among these bacteria may reflect adaptations to different habitats.
Enterobacter ludwigii, a member of the
E. cloacae complex, is a plant growth-promoting rhizobacterium, as well as an enteric commensal and opportunistic human pathogen (
29,
30).
E. ludwigii UW5 (renamed from
Enterobacter cloacae UW5 based on genomic average nucleotide identity) synthesizes high levels of the plant growth hormone indole-3-acetic acid (IAA) when tryptophan is supplied exogenously (
29). In this bacterium, IAA is produced from tryptophan via indole-3-pyruvate, which is converted to indole-3-acetaldehyde by indolepyruvate decarboxylase, encoded by
ipdC. The expression of
ipdC is wholly dependent on TyrR and is upregulated by aromatic amino acids, especially phenylalanine (
29,
31). Transcriptional activation of
ipdC occurs by TyrR binding to a promoter-proximal strong box centered 30 bp upstream from the −35 element. A second TyrR box further upstream overlaps the −10 element of the divergently transcribed
akr gene promoter and represses its expression (
31). This second weak box has atypical spacing of the left and right palindromic arms, which are separated by 2 or 8 base pairs rather than by the canonical 6, yet binding by TyrR has been demonstrated
in vitro (
31). The
akr homologue in
E. coli encodes an
l-glyceraldehyde-3-phosphate reductase, which along with
l-glyceraldehyde dehydrogenase generates dihydroxyacetone phosphate for gluconeogenesis (
32). The novel finding that, in
E. ludwigii, TyrR controls expression of enzymes for tryptophan catabolism and gluconeogenesis indicates that its function is more diverse than that of
E. coli TyrR. In this study, we aimed to delineate the TyrR regulon in
E. ludwigii UW5 by comparing the genome-wide transcriptional profiles in the wild-type and a
tyrR mutant strain. We found that TyrR controls an expanded regulon in
E. ludwigii, significantly altering expression of genes and operons for anaerobic respiration and aromatic catabolism and directly activating transcription of a methyltransferase gene. Moreover, TyrR mediates changes in the Cpx stress envelope response pathway by repressing transcription of the
cpx operon.
MATERIALS AND METHODS
Bacterial strains and growth conditions.
The bacterial strains and plasmids used in this study are listed in Table S1 in the supplemental material. Bacteria were routinely cultured in Luria-Bertani (LB) broth with shaking at 250 rpm and incubated at 37°C for E. coli or at 30°C for E. ludwigii. To measure TyrR-responsive gene expression, E. ludwigii was grown in M9 minimal medium supplemented with 1 mM l-tryptophan, l-phenylalanine, or l-tyrosine. Antibiotics were used at the following concentrations: 100 μg/ml ampicillin, 25 μg/ml kanamycin, 25 μg/ml gentamicin, or 25 μg/ml chloramphenicol.
Construction of a tyrR deletion mutant.
The entire
tyrR coding sequence, up to and including the start and stop codons, was removed from the
E. ludwigii chromosome. The
tyrR sequence was initially replaced via homologous recombination with a kanamycin resistance gene flanked by flippase (Flp)-mediated Flp recognition target (FRT) sites that, following selection, was subsequently excised by Flp to avoid introduction of an antibiotic resistance gene (
91). The upstream and downstream regions of the genome flanking the
tyrR sequence were amplified from wild-type
E. ludwigii genomic DNA using the primer pairs TUF-PstI and TUR-XbaI and TDF-XbaI and TDR-SacI, respectively (see Table S2 in the supplemental material). Purified PCR products were used as the templates for splicing by overlap extension PCR with primers TUF-PstI and TDR-SacI to yield a 1.5-kb fragment which was subsequently ligated into pGEM-T Easy (Promega), generating plasmid pTUD. Plasmid pTUD was transformed into
E. coli JM109, and transformants were selected on ampicillin. The FRT-flanked kanamycin (Km) resistance gene was amplified from plasmid pKD4 using primers PKDP1 and PKDP2 and ligated into XbaI-digested pTUD, resulting in plasmid pTUD-Km, which was transformed into
E. coli JM109. The 3-kb TUD-Km cassette was excised from pTUD-Km via NotI digestion and ligated with similarly digested pJQ200SK, creating pJQTUD-Km. pJQTUD-Km was transformed into
E. coli S17-1λpir and subsequently introduced into wild-type
E. ludwigii by conjugation. Single recombinants were identified by gentamicin and kanamycin resistance, sucrose sensitivity (conferred by
sacB on pJQ200SK), and PCR amplification of the kanamycin resistance gene with primers PKDP1 and PKDP2. Subsequently, the pJQ200SK backbone was selected against by growing single recombinants overnight in LB broth with 10% sucrose, and plating on LB kanamycin with 10% sucrose. Double recombinants were screened for gentamicin sensitivity and kanamycin resistance, and verified by PCR amplification with primers TUF and TUR, and TDF and TDR, which anneal outside the region used for homologous recombination. The kanamycin resistance gene was removed by transforming calcium chloride-competent cells with plasmid pCP20 encoding Flp recombinase and selecting on chloramphenicol-containing medium. Positive transformants were grown overnight in LB broth at 37°C to induce expression of the Flp recombinase and inhibit pCP20 replication. Loss of the kanamycin resistance gene was verified by kanamycin sensitivity, PCR amplification with primers TUF and TDR, and sequencing of the amplified product. Verified
tyrR mutants (
E. ludwigii J224) were stored at −80°C.
IAA quantification.
Because IAA production in
E. ludwigii is wholly dependent on TyrR-mediated expression of the
ipdC gene (
29), colorimetric quantification of IAA was used to validate the loss of TyrR activity.
E. ludwigii wild-type and
tyrR mutant strains were grown overnight in LB broth, pelleted, and washed twice with 1× M9 salts (Difco), before inoculation 1:100 into M9 minimal medium or M9 medium supplemented with 1 mM tryptophan. IAA production was quantified by the method of Gordon and Weber (
92) after 24 h of incubation at 30°C. Culture turbidity at OD
600 was recorded before pelleting 1 ml of cells and transferring 40 μl of culture supernatant to a 96-well plate containing 160 μl Salkowski’s reagent (36% [vol/vol] H
2SO
4, 10 mM FeCl
3). Reaction mixtures were incubated at room temperature for 20 min before quantification of absorbance at OD
535 on a SpectraMax M5 plate reader (Molecular Devices). Total IAA was determined by extrapolating from a standard curve of known concentration and normalized to culture turbidity.
RNA isolation and sequencing.
Overnight cultures from single colonies of wild-type and tyrR mutant E. ludwigii were inoculated 1:100 into 3 ml fresh LB in quadruplicate and incubated at 30°C and 250 rpm for ∼2.5 h until reaching the mid-logarithmic phase of growth (OD600 = 0.6 to 0.9). A total of 0.5 ml of cell suspension were then transferred to a 2 ml tube containing 1 ml RNAprotect bacteria reagent (Qiagen, Hilden, Germany), vortexed, and incubated for 5 min at room temperature before pelleting by centrifugation. Cell pellets were stored at −20°C until further use. Frozen cell pellets were thawed on ice and resuspended with 15 mg/ml lysozyme and 15 mg/ml proteinase K in 200 μl TE buffer (10 mM Tris-HCl [pH 8.0], 1 mM EDTA) to lyse cells for 10 min at 4°C with periodic vortexing. Total RNA was then extracted using the RNeasy minikit (Qiagen) according to the manufacturer’s instructions. RNA quality and quantity were measured on a SpectraMax M5 plate reader and visualized by agarose gel electrophoresis to ensure sample integrity. Contaminating genomic DNA was removed by treating 5 μg total RNA in a 50 μl reaction mixture containing 5 units amplification grade DNase I (Invitrogen, CA) and 5 μl 10× DNase I digestion buffer and incubating at 37°C for 60 min. The reaction was terminated with 1 mM (final concentration) EDTA and heating at 70°C for 10 min. The DNase-treated RNA was purified using the Qiagen MinElute cleanup kit (Qiagen) and eluted into 30 μl of RNase-free water. DNA removal was verified by performing quantitative real-time PCR with the ipdC gene as the template on each DNase-treated RNA sample using primers ICRTIF and ICRTIR (see Table S2 in the supplemental material). Samples that yielded no amplicons or crossing point (Cp) values greater than 30 were considered acceptable for library preparation. The final quality and quantity of RNA samples were measured on an Agilent Bioanalyzer-RNA 6000 Pico chip (Agilent Technologies, CA). Construction of RNA-Seq libraries and sequencing were performed by the Genome Quebec Innovation Centre (Montreal, Quebec, Canada). rRNA was removed using the Ribo-Zero rRNA removal kit for Gram-negative bacteria (Illumina). The resulting enriched mRNA was used to construct a 100-bp paired-end stranded Illumina library using the TruSeq RNA library prep kit v2 (Illumina) following the manufacturer’s instructions. The libraries were individually barcoded and sequenced together on a single Illumina HiSeq 2000 lane.
RNA-Seq data analysis.
Sequence data were inspected for overall quality using FastQC v0.11.2 (S. Andrews;
http://www.bioinformatics.babraham.ac.uk/projects/fastqc/). Low-quality reads and contaminating Illumina TruSeq adapter sequences were removed using Trimmomatic v0.3 (
93) with a sliding window size of 4 bp, cutting sequences when the average Phred score dropped below 15. Surviving paired reads were mapped to the
E. ludwigii UW5 reference genome (GenBank accession number
CP011798) (
94) using Burrows-Wheeler Aligner (BWA) (v0.7.9-r789) (
95) as single fragments with a maximum mismatch of 1%. Read alignments were sorted, indexed, and converted to BAM format with SAMtools v0.1.19-44428cd (
96). Sample read alignments were visualized using the Integrative Genomics Viewer v2.3.32 (
97) to ensure correct mapping of reads to genomic features. The number of reads that mapped to each genomic feature was calculated using the default parameters of HTSeq-count v0.6.1.p1 (
98). Genes with significantly different levels of expression between wild-type and
tyrR mutant strains were called using DESeq2 v1.12.4 (
99). Genes were considered to be differentially expressed when there was at least a 4-fold change (i.e., |log
2FC| > 2) in expression with a false-discovery rate (FDR) threshold-adjusted
P value (
Padj) of ≤0.001 as determined by the Benjamini-Hochberg correction method (
99).
Pathway enrichment analysis.
Gene ontology (GO) terms were mapped to the annotated
E. ludwigii UW5 genome using Blast2GO (
37,
100,
101). R version 3.4.3 (
102) was used for statistical analysis and plotting of data. The Bioconductor package GOseq 1.30.0 (
36) was employed to identify over- and underrepresented GO terms present in the differentially expressed data set applying the Wallenius distribution approximation, and significantly enriched terms were determined by applying an FDR cutoff of 0.05 using the Benjamini-Hochberg adjustment. REVIGO was used to visualize the distribution of GO terms according to the major GO classifications (biological processes, cellular components, and molecular function) (
103). Coverage plots for mapped RNA-Seq data were generated with the Bioconductor package Gviz 1.22.3 (
104).
Quantitative reverse transcriptase PCR.
To quantify target mRNAs by PCR, cultures of E. ludwigii wild-type and tyrR mutant strains were grown (in triplicate) in LB broth or in M9 minimal medium supplemented with 1 mM aromatic amino acid. RNA was purified, quantified, and treated with DNase I to remove genomic DNA as described above for RNA-Seq sample preparation. cDNA was generated by mixing 100 ng DNase I-treated RNA, 20 pmol of gene-specific reverse primer (Table S2) and 10 nmol deoxynucleoside triphosphates (dNTPs) in a final volume of 13 μl. The reaction mixture was incubated at 65°C for 5 min before it was placed on ice for 1 min. To each cDNA reaction mixture, 4 μl first-strand synthesis buffer (Invitrogen), 1 μl 0.1 M dithiothreitol, 1 μl RNaseOUT (Invitrogen), and 1 μl SuperScript III reverse transcriptase (RT) (Invitrogen) were added, and the mixture was incubated at 55°C for 1 h. Controls without reverse transcriptase were prepared in identical reaction mixtures. cDNA synthesis was stopped by heating at 70°C for 10 min, and samples were stored at −20°C.
Duplicate real-time quantitative PCRs were performed with each cDNA in 25 μl reaction mixtures containing the following components: 200 nM each forward and reverse primer (Table S2), 12.5 μl Platinum
Taq SYBR green mastermix (Invitrogen), and 4 μl cDNA corresponding to 100 ng total RNA. Quantitative RT-PCR was performed on a Rotor-Gene 6000 thermocycler (Corbett Life Science, Sydney, Australia) with the following cycling conditions: initial denaturation at 98°C for 2 min, followed by 40 cycles of denaturation at 98°C for 10 s, primer annealing at 51°C (
aroG and
proP), 57°C (
recA,
cpxP, and
cpxR), or 61°C (
yagU,
eco, and
dmpM) for 15 s, and elongation at 72°C for 20 s with acquisition of the fluorescent signal. A melting curve analysis was performed at the completion of each run by raising temperature from 60°C to 95°C in 1°C increments every 5 s with acquisition of fluorescent signal. The raw data were exported into LinRegPCR to determine individual reaction efficiencies and calculate corresponding Cp values (
105). These values were imported into the Relative Expression Software Tool (REST) to calculate relative expression ratios between treatments, normalized with reference gene
recA (
106), using the threshold cycle (ΔΔ
CT) method (
107,
108).
Purification of His6-TyrR.
Purification of His
6-TyrR was performed as previously described (
31). Briefly, overnight cultures of
E. coli A118 were subcultured 1:100 into 50 ml fresh LB medium and grown at 37°C and 250 rpm for 4 h until reaching an OD
600 value of 0.4. Expression of His
6-TyrR from plasmid pQEtyrR was induced with 1 mM isopropyl-β-
d-1-thiogalactopyranoside (IPTG), and cells were incubated for a further 4 h before harvesting by centrifugation. Cell pellets were stored at −20°C until further use. Cell pellets were thawed on ice and resuspended in lysis buffer (50 mM NaH
2PO
4, 300 mM NaCl, and 10 mM imidazole [pH 8.0]) with 1 mg/ml lysozyme (Sigma-Aldrich, ON, Canada) for 30 min. Cells were fully lysed while on ice with six 10-s bursts at 26 W using a Sonic Dismembrator model 100 (Fisher Scientific, ON, Canada). His
6-TyrR was purified using Ni-nitrilotriacetic acid (NTA) resin (Qiagen) according to the manufacturer’s protocol for protein purification under native conditions, with the following exceptions: wash buffer 1, 50 mM NaH
2PO
4, 300 mM NaCl, and 20 mM imidazole (pH 8.0); wash buffer 2, 50 mM NaH
2PO
4, 300 mM NaCl, 20 mM imidazole, and 10% glycerol (pH 8.0). Purified protein was eluted four times with 0.5 ml elution buffer (50 mM NaH
2PO
4, 300 mM NaCl, 250 mM imidazole, and 8% glycerol [pH 8.0]) and stored in aliquots at −80°C.
Electrophoretic mobility shift assays.
Wild-type cpx and dmpM promoters, and cpx promoters with specific point mutations in predicted TyrR boxes (see Table S3 in the supplemental material) were synthesized by Integrated DNA Technologies (IDT, Coralville, IA) and provided on sequence-verified plasmids (Table S1). Site-directed mutagenesis was used to introduce mutations in each of the predicted TyrR boxes in the dmpM promoter (Table S3) creating pUCdmpM-mut1 and pUCdmpM-mut2 (Table S1). Triplicate PCRs were performed in 50-μl volumes containing 125 μmol each forward and reverse primer (box 1, SDM1-F and SDM1-R; box 2, SDM2-F and SDM2-R) (Table S2), 0.5 μl Phusion Taq polymerase (New England Biolabs [NEB], ON, Canada), 1 μl dNTPs, and 25 ng pUCdmpM as the template with the following cycling conditions: 95°C for 2 min, 12 cycles of at 95°C for 30 s, annealing at 60°C for 60 s, and elongation at 72°C for 90 s. PCR products were pooled and digested with 3 μl DpnI (NEB) at 37°C for 2 h. The digested DNA was PCR purified (Qiagen), eluted into 10 μl double-distilled water (ddH2O), and transformed into E. coli JM109. The TyrR box 1 and 2 double mutant (pUCdmpM-mut3) was created by repeating the mutagenesis PCR using primers SDM2-F2 and SDM2-R with pUCdmpM-mut1 as the template. All plasmid sequences were verified by sequencing. To generate 6-carboxyfluoroscein (FAM) end-labeled probes for EMSAs, plasmids carrying the wild-type and mutant promoter sequences were used as the templates for PCR with primers cpx-F1 and cpx-R-FAM or dmpM-F1 and dmpM-R-FAM (Table S2) to amplify the cpxR-cpxP intergenic region and dmpM promoter region, respectively. Labeled PCR products were purified using the Qiagen PCR purification kit.
Protein-DNA binding reactions were performed as described previously (
31). Briefly, His
6-TyrR was added to 5 μl 5× binding buffer (50 mM Tris-Cl [pH 7.5], 250 mM NaCl, 5 mM MgCl
2, 20% glycerol, 2.5 mM dithiothreitol, and 2.5 mM EDTA), 1 μg poly(dI-dC) (nonspecific competitor), and 1 mM aromatic amino acid (with 0.1 mM ATP when tyrosine was added), and was incubated at room temperature for 5 min. Afterwards, 100 ng 6-FAM-labeled DNA was added to the reaction and incubated for 30 min at room temperature. Reactions were stopped with 5 μl loading buffer (0.25× Tris-borate-EDTA [TBE], 60% glycerol, and 0.001% bromophenol blue) and loaded onto prerun 6% native polyacrylamide gels containing 1 mM aromatic amino acid (with 0.1 mM ATP when tyrosine was added). Protein-DNA complexes were resolved at 100 V at 4°C for ∼120 min and visualized on a ChemiDoc MP imager (Bio-Rad, CA). Band intensity was quantified using Image Lab software v6.0.1 (Bio-Rad).
DNase I footprinting assays.
FAM end-labeled probes for DNase I footprinting assays were generated by PCR using primers dmpM-F-FAM and dmpM-R for the dmpM promoter region and primers cpx-F-FAM and cpx-R for the cpxR-cpxP intergenic region (Table S2), and pUCdmpM or pIDTcpx, respectively, as the templates (Table S1). Labeled PCR products (302 bp for dmpM and 238 bp for cpxR-cpxP) were purified from polyacrylamide gels using the Qiagen PCR purification kit. Probes (100 ng) were incubated with various concentrations of purified His6-TyrR (0 to 3 μg for dmpM and 0 to 6 μg for cpxR-cpxP) or bovine serum albumin (BSA, 0 to 30 μg) in binding buffer (10 mM Tris-Cl [pH 7.5], 50 mM NaCl, 1 mM MgCl2, 4% glycerol, 0.5 mM dithiothreitol, 0.5 mM EDTA, and 1 μg poly[d(I-C)]), with or without 1 mM tyrosine, for 30 min at room temperature. DNase I (0.02 U; NEB), 2.5 μl 10× DNase buffer, and 1.5 μl ddH2O were added, the mixture was incubated at room temperature for 2 min, and then the reaction was stopped with 1 μl 0.5 M EDTA and heating at 75°C for 10 min. Reaction mixtures were brought to a total volume of 100 μl with elution buffer (EB, Qiagen) and mixed with an equal volume of phenol-chloroform-isoamyl alcohol (25:24:1 vol/vol) with 1 min of vortexing. Samples were centrifuged for 5 min at 13,000 × g and the aqueous phase aspirated to a new tube. Each sample was mixed with 1 μg glycogen (NEB), 1:10 volume 3 M sodium acetate, and 4 volumes of 100% ethanol. DNA was precipitated overnight at −80°C. Samples were centrifuged for 30 min at 13,000 × g and the supernatant was discarded. The DNA pellet was washed twice with ice-cold 80% ethanol, centrifuged for 10 min at 13,000 × g, and ethanol discarded. After air drying the pellet to remove residual ethanol, DNA was resuspended in 10 μl EB buffer overnight at 4°C. Two microliters of each sample was mixed with GeneScan 500 LIZ size standard (Applied Biosystems) and resolved by capillary electrophoresis at the Genome Quebec Innovation Centre on an ABI-3730XL DNA Analyzer using Peak Scanner software (Applied Biosystems). The peaks representing DNA fragment sizes were analyzed using Geneious Prime 2020 software with the microsatellite plug-in (Biomatters Ltd., Auckland, New Zealand) and aligned with peaks from a dideoxynucleotide sequencing reaction (Thermo Sequenase Dye Primer Manual cycle sequencing kit, Thermo Fisher Scientific) with a FAM-labeled primer for each promoter region.
Data availability.
The
E. ludwigii UW5 genome used in this study was previously sequenced and annotated (
94) and is available from the NCBI GenBank database under the accession number
CP011798. The raw RNA sequence data are available in the Gene Expression Omnibus database under the accession number
GSE122440.